Biopsy Devices Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes | DelveInsight

The Global Biopsy Devices market is expected to expand at a CAGR of 5.1% between 2025 and 2032. This growth is driven by factors such as the increasing prevalence of breast cancer, a growing elderly population, rising lung cancer cases, and continuous technological advancements in biopsy device offerings. Consequently, the biopsy devices market is projected to experience steady growth throughout the forecast period from 2025 to 2032.

DelveInsight's Biopsy Devices Market Insights report provides the current and forecast market analysis, individual leading Biopsy Devices companies' market shares, challenges, Biopsy Devices market drivers, barriers, and trends, and key Biopsy Devices companies in the market.

Request for a sample report: https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Biopsy Devices Market Report
• The Biopsy Devices market is projected to grow at a moderate CAGR from 2025 to 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global Biopsy Devices market during the forecast period.
The Biopsy Devices Market is a dynamic and rapidly developing segment within the healthcare industry, essential for diagnosing and treating a wide range of medical conditions. This market includes various types of biopsy tools such as needle-based biopsy instruments, core biopsy systems, and vacuum-assisted biopsy devices, among others.
Key players in the Biopsy Devices Market include Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook, Devicor Medical Products Inc, B. Braun Melsungen AG, ARGON MEDICAL, OLYMPUS CORPORATION, FUJIFILM, INRAD Inc, Hologic Inc, C. R. Bard, Dr. Japan Co Ltd, Limaca-medical, Owlstone Medical Ltd, Zamar Care, KOELIS, ST. STONE MEDICAL DEVICES PVT LTD, Iscon Surgicals Ltd, and several others.
In May 2022, Limaca Medical, a privately held Israeli company focused on improving endoscopic biopsy outcomes for patients with potentially life-threatening gastrointestinal tumors, received FDA breakthrough device designation for its Precision GI endoscopic ultrasound biopsy device. The Precision GI device is inserted and operated through the endoscope's instrument channel to biopsy tumors.
Also in May 2022, Limaca Medical announced a strategic partnership with HekaBio K.K., a privately held healthcare company based in Tokyo, Japan. Under this agreement, HekaBio will distribute Limaca's Precision-GITM Endoscopic Biopsy Device within the Japanese market.
In July 2019, FUJIFILM Medical Systems U.S.A., Inc., a prominent provider of diagnostic imaging and medical informatics solutions, expanded its breast imaging offerings by launching the Tomosynthesis Biopsy option for the ASPIRE Cristalle mammography system. This new option supplements the traditional stereotactic method by using tomosynthesis guidance to calculate the 3D coordinates of suspicious breast lesions, enabling radiologists to accurately perform biopsies for pathological examination, diagnosis, and treatment planning.

To read more about the latest highlights related to the Biopsy Devices market, get a snapshot of the key highlights entailed in the Global Biopsy Devices Market Report @ https://www.delveinsight.com/sample-request/biopsy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Biopsy Devices Overview

Biopsy devices are essential tools in medical diagnostics, enabling the collection of tissue samples from the body to detect and diagnose various diseases, including cancers and infections. This market includes a variety of instruments such as needle biopsy devices, core biopsy systems, and vacuum-assisted biopsy tools, each designed for specific biopsy procedures and clinical needs. These devices play a critical role in providing accurate and minimally invasive diagnostic solutions that guide effective treatment planning. Major companies in the biopsy devices sector include Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook Medical, FUJIFILM, Hologic Inc., and others, driving innovation and development in this evolving healthcare segment.


Biopsy Devices Market Insights

In 2022, North America led the global biopsy devices market and is projected to maintain this dominance throughout the forecast period from 2025 to 2032. The increasing incidence of lung cancer and ongoing technological advancements in biopsy device offerings are key factors driving the demand for biopsy devices in the North American market.

According to data published by the American Cancer Society in 2023, the United States was estimated to have 236,740 new lung cancer cases in 2022. Biopsy devices play a critical role in diagnosing lung cancer, and thus, the rising number of cases is expected to boost the demand for these devices, fueling overall market growth.

Additionally, advancements in biopsy technology are further propelling market expansion. For example, in October 2020, GE Healthcare introduced the Serena Bright contrast-enhanced guided biopsy solution in the U.S., aimed at improving breast cancer outcomes. This innovative technology allows clinicians to perform breast biopsies with contrast guidance using the same mammography equipment and staff, enhancing efficiency and patient care.


To know more about why North America is leading the market growth in the Biopsy Devices market, get a snapshot of the Biopsy Devices Market Outlook @https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Biopsy Devices Market Dynamics

A key driver of the Biopsy Devices market is the rising prevalence of breast cancer. According to data published by the World Health Organization (WHO) in 2021, breast cancer was diagnosed in 2.3 million women globally in 2020, with a total of 7.8 million cases reported over the previous five years ending in 2020. Biopsy devices play a crucial role in diagnosing breast cancer and supporting effective treatment, thereby increasing the demand for these devices and propelling market growth throughout the forecast period from 2025 to 2032.

Another significant factor contributing to the growth of the biopsy devices market is the increasing geriatric population. WHO data from 2021 estimates that the global population aged 60 and above will nearly double from 12% in 2015 to 22% by 2050, reaching 2.1 billion people. By 2032, it is projected that one in every six individuals worldwide will be aged 60 or older. Furthermore, the population aged 80 and above is expected to triple between 2020 and 2050, reaching 426 million. As people age, their risk of developing diseases such as cancer, infections, and autoimmune disorders rises, which in turn drives higher demand for biopsy devices. This demographic trend supports the expansion of the biopsy devices market over the forecast period of 2025 to 2032.

Overall, these factors collectively stimulate demand for biopsy devices, fueling significant growth in the global biopsy devices market during the forecast period from 2025 to 2032.


Biopsy Devices Market Drivers:

The Biopsy Devices market is experiencing steady growth driven by factors such as the growing prevalence of breast cancer, an increasing elderly population, a rise in lung cancer cases, and ongoing technological advancements in product development.

Get a sneak peek at the Biopsy Devices market dynamics @ https://www.delveinsight.com/sample-request/biopsy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Coverage: Global
Study Period: 2022 to 2032
Key Biopsy Devices Companies: Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook, Devicor Medical Products Inc, B. Braun Melsungen AG, ARGON MEDICAL, OLYMPUS CORPORATION, FUJIFILM, INRAD Inc, Hologic Inc, C. R. Bard, Dr. Japan Co Ltd, Limaca-medical, Owlstone Medical Ltd, Zamar Care, KOELIS, ST. STONE MEDICAL DEVICES PVT LTD, Iscon Surgicals Ltd, and others.

Which MedTech key players in the Biopsy Devices market are set to emerge as the trendsetter, explore @ Biopsy Devices Companies https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Table of Contents
1. Biopsy Devices Market Report Introduction
2. Biopsy Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Biopsy Devices Market Key Factors Analysis
6. Biopsy Devices Market Porter's Five Forces Analysis
7. Biopsy Devices Market Layout
8. Biopsy Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Contact Info:
Kritika Rehani
Assistant Manager, Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.